longbridgelongbridge
  • 平台特色
    特色
    投资产品私人财富管理交易工具行情服务分析工具资讯服务开发者平台
    账户类型
    个人客户机构客户
  • Café
longbridge
© 2026 Longbridge|服务条款隐私政策

Telix Pharmaceuticals

TLX

11.8507.64% ( -0.980 )
交易中: 9月16日 09:36:38 (美东)
开始交易
概览概览期权链期权链新闻新闻讨论讨论财务财务预测预测估值估值股东股东简况简况
LongbridgeAI
全部股东机构持有者内部人士

全部股东

股东类型

  • 机构投资者43.13%
  • 公众及其他37.40%
  • 个人与内部人士14.83%
  • 上市公司3.22%
  • 私营企业1.42%

主要股东

主要股东 最新
股东
JPMorgan Chase & Co.
8.96%3,043.73 万1.23%+418.16 万2026/07/21
State Street Investment Management
7.04%2,393.03 万1.65%-561.54 万2026/07/06
Andreas KlugeChief Medical Advisor
6.67%2,267.50 万0.01%+02025/02/06
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director
6.41%2,179.69 万<0.01%+6.79 万2026/05/26
Challenger Limited
4.98%1,690.73 万0.07%-19.52 万2026/05/04
Citigroup Inc.
3.35%1,139.14 万0.01%+6.04 万2026/06/30
Grand Pharmaceutical Group Limited
3.22%1,094.72 万<0.01%+02026/02/06
Vanguard Capital Management, LLC
3.12%1,059.30 万<0.01%+2.07 万2026/07/31
Australian Super Pty Ltd
2.26%768.79 万<0.01%+02025/12/31
Vanguard Investments Australia Limited
1.88%640.17 万0.02%+6.70 万2026/07/31
BlackRock, Inc.
1.75%595.87 万0.02%-5.14 万2026/06/30
UV-Cap GmbH & Co KG
1.44%487.83 万<0.01%+02026/02/06
Norges Bank Investment Management
1.35%459.90 万0.54%-183.01 万2026/06/30
Mark NelsonIndependent Non-Executive Director
1.07%362.88 万<0.01%+02026/03/18
Oncidium Foundation
0.74%251.36 万<0.01%+02026/02/06
Netwealth Investments Ltd.
0.71%240.66 万<0.01%+02026/02/06
BetaShares Capital Limited
0.59%200.52 万0.02%+5.15 万2026/08/31
Sanlam Investments Uk Limited
0.58%195.95 万<0.01%+02025/06/30
Lightpoint Medical Ltd
0.56%191.81 万<0.01%+02026/02/06
Yelwac Pty Ltd
0.52%176.25 万<0.01%+02025/02/06